FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders.

Abstract:

BACKGROUND:Fos-related antigen 1 (FRA-1) is an immediate early gene encoding a member of AP-1 family of transcription factors involved in cell proliferation, differentiation, apoptosis, and other biological processes. fra-1 gene overexpression has an important role in the process of cellular transformation, and our previous studies suggest FRA-1 protein detection as a useful tool for the diagnosis of thyroid neoplasias. Here we investigate the expression of the FRA-1 protein in benign and malignant breast tissues by immunohistochemistry, Western blot, RT-PCR and qPCR analysis, to evaluate its possible help in the diagnosis and prognosis of breast neoplastic diseases. METHODS:We investigate the expression of the FRA-1 protein in 70 breast carcinomas and 30 benign breast diseases by immunohistochemistry, Western blot, RT-PCR and qPCR analysis. RESULTS:FRA-1 protein was present in all of the carcinoma samples with an intense staining in the nucleus. Positive staining was also found in most of fibroadenomas, but in this case the staining was present both in the nucleus and cytoplasm, and the number of positive cells was lower than in carcinomas. Similar results were obtained from the analysis of breast hyperplasias, with no differences in FRA-1 expression level between typical and atypical breast lesions; however the FRA-1 protein localization is mainly nuclear in the atypical hyperplasias. In situ breast carcinomas showed a pattern of FRA-1 protein expression very similar to that observed in atypical hyperplasias. Conversely, no FRA-1 protein was detectable in 6 normal breast tissue samples used as controls. RT-PCR and qPCR analysis confirmed these results. Similar results were obtained analysing FRA-1 expression in fine needle aspiration biopsy (FNAB) samples. CONCLUSION:The data shown here suggest that FRA-1 expression, including its intracellular localization, may be considered a useful marker for hyperplastic and neoplastic proliferative breast disorders.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Chiappetta G,Ferraro A,Botti G,Monaco M,Pasquinelli R,Vuttariello E,Arnaldi L,Di Bonito M,D'Aiuto G,Pierantoni GM,Fusco A

doi

10.1186/1471-2407-7-17

subject

Has Abstract

pub_date

2007-01-25 00:00:00

pages

17

issn

1471-2407

pii

1471-2407-7-17

journal_volume

7

pub_type

杂志文章
  • Different next-generation sequencing pipelines based detection of tumor DNA in cerebrospinal fluid of lung adenocarcinoma cancer patients with leptomeningeal metastases.

    abstract:BACKGROUND:The nucleic acid mutation status in intracranial metastasis is markedly significant clinically. The goal of the current study was to explore whether the tumor-associated mutations can be detected by different next-generation sequencing (NGS) pipelines in paired cerebrospinal fluid (CSF) and plasma samples fr...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5348-3

    authors: Ge M,Zhan Q,Zhang Z,Ji X,Zhou X,Huang R,Liang X

    更新日期:2019-02-12 00:00:00

  • Therapeutic limitations in tumor-specific CD8+ memory T cell engraftment.

    abstract:BACKGROUND:Adoptive immunotherapy with cytotoxic T lymphocytes (CTL) represents an alternative approach to treating solid tumors. Ideally, this would confer long-term protection against tumor. We previously demonstrated that in vitro-generated tumor-specific CTL from the ovalbumin (OVA)-specific OT-I T cell receptor tr...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-3-21

    authors: Bathe OF,Dalyot-Herman N,Malek TR

    更新日期:2003-07-28 00:00:00

  • Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: a subanalysis from a phase 3 trial (MPACT).

    abstract:BACKGROUND:The phase 3 MPACT trial in patients with metastatic pancreatic cancer demonstrated superior efficacy of nab-paclitaxel (nab-P) + gemcitabine (Gem) vs Gem monotherapy for all endpoints examined including overall survival, the primary endpoint. In the MPACT trial, patients were treated until progressive diseas...

    journal_title:BMC cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s12885-016-2798-8

    authors: Vogel A,Römmler-Zehrer J,Li JS,McGovern D,Romano A,Stahl M

    更新日期:2016-10-21 00:00:00

  • Inter-observer agreement according to three methods of evaluating mammographic density and parenchymal pattern in a case control study: impact on relative risk of breast cancer.

    abstract:BACKGROUND:Mammographic breast density and parenchymal patterns are well-established risk factors for breast cancer. We aimed to report inter-observer agreement on three different subjective ways of assessing mammographic density and parenchymal pattern, and secondarily to examine what potential impact reproducibility ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1256-3

    authors: Winkel RR,von Euler-Chelpin M,Nielsen M,Diao P,Nielsen MB,Uldall WY,Vejborg I

    更新日期:2015-04-12 00:00:00

  • Moderate to vigorous physical activity participation associated with better quality of life among breast and colorectal cancer survivors in Korea.

    abstract:BACKGROUND:To investigate the association between physical activity (PA) and quality of life (QoL) among breast and colorectal cancer survivors in Korea. METHODS:A total of 224 cancer survivors (151 breast and 73 colorectal cancers) who completed treatments were recruited. We measured PA level with Godin Leisure-Time ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06819-z

    authors: Park JH,Lee DH,Kim SI,Kim NK,Jeon JY

    更新日期:2020-05-01 00:00:00

  • Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients.

    abstract:BACKGROUND:Circulating tumour DNA (ctDNA) may serve as a measure of tumour burden and a useful tool for non-invasive monitoring of cancer. However, ctDNA is not always detectable in patients at time of diagnosis of metastatic disease. Therefore, there is a need to understand the correlation between ctDNA levels and the...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4637-6

    authors: McEvoy AC,Warburton L,Al-Ogaili Z,Celliers L,Calapre L,Pereira MR,Khattak MA,Meniawy TM,Millward M,Ziman M,Gray ES

    更新日期:2018-07-09 00:00:00

  • The effect of length of birth interval on the risk of breast cancer by subtype in grand multiparous women.

    abstract:BACKGROUND:The length of interval between successive childbirths (birth interval) might influence the incidence of breast cancer, either by stimulating or by inhibiting the factors that are responsible for the initiation of breast cancer or its early development. METHODS:This is a case-control study nested in a cohort...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5404-z

    authors: Katuwal S,Tapanainen JS,Pukkala E,Kauppila A

    更新日期:2019-03-04 00:00:00

  • Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial.

    abstract:BACKGROUND:Axonal sensory peripheral neuropathy is the major dose-limiting side effect of paclitaxel.Omega-3 fatty acids have beneficial effects on neurological disorders from their effects on neurons cells and inhibition of the formation of proinflammatory cytokines involved in peripheral neuropathy. METHODS:This stu...

    journal_title:BMC cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1186/1471-2407-12-355

    authors: Ghoreishi Z,Esfahani A,Djazayeri A,Djalali M,Golestan B,Ayromlou H,Hashemzade S,Asghari Jafarabadi M,Montazeri V,Keshavarz SA,Darabi M

    更新日期:2012-08-15 00:00:00

  • Evaluation of the interval cancer rate and its determinants on the Girona Health Region's early breast cancer detection program.

    abstract:BACKGROUND:The main aim of this study is to estimate the rate of false negative and true IC on the Program for the Early Detection of Breast Cancer (PEDBC) run by the Girona Health Region (GHR) and compare the clinicopathological characteristics of these tumors with those detected within the same program. METHODS:A re...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-558

    authors: Renart-Vicens G,Puig-Vives M,Albanell J,Castañer F,Ferrer J,Carreras M,Tarradas J,Sala M,Marcos-Gragera R

    更新日期:2014-08-01 00:00:00

  • Preoperative serum 8-hydroxydeoxyguanosine is associated with chemoresistance and is a powerful prognostic factor in endometrioid-type epithelial ovarian cancer.

    abstract:BACKGROUND:Oxidative stress is a widely seen phenomenon in several carcinomas. Increasing evidence also suggests that it has a significant role in the development of epithelial ovarian carcinoma (EOC). 8-Hydroxydeoxyguanosine (8-OHdG) is one of the main indicators of oxidative stress and increased expression of 8-OHdG ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1504-6

    authors: Pylväs-Eerola M,Karihtala P,Puistola U

    更新日期:2015-07-02 00:00:00

  • Metabolic consequences of perioperative oral carbohydrates in breast cancer patients - an explorative study.

    abstract:BACKGROUND:The metabolic consequences of preoperative carbohydrate load in breast cancer patients are not known. The present explorative study investigated the systemic and tumor metabolic changes after preoperative per-oral carbohydrate load and their influence on tumor characteristics and survival. METHODS:The study...

    journal_title:BMC cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s12885-019-6393-7

    authors: Lende TH,Austdal M,Bathen TF,Varhaugvik AE,Skaland I,Gudlaugsson E,Egeland NG,Lunde S,Akslen LA,Jonsdottir K,Janssen EAM,Søiland H,Baak JPA

    更新日期:2019-12-04 00:00:00

  • Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast.

    abstract:BACKGROUND:Loss of DNA mismatch repair (MMR) in humans, mainly due to mutations in the hMLH1 gene, is linked to hereditary nonpolyposis colorectal cancer (HNPCC). Because not all MLH1 alterations result in loss of MMR function, accurate characterization of variants and their classification in terms of their effect on M...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-382

    authors: Vogelsang M,Comino A,Zupanec N,Hudler P,Komel R

    更新日期:2009-10-28 00:00:00

  • Western influenced lifestyle and Kv2.1 association as predicted biomarkers for Tunisian colorectal cancer.

    abstract:BACKGROUND:Colorectal cancer (CRC) is the third most diagnosed malignancy worldwide. The global burden is expected to increase along with ongoing westernized behaviors and lifestyle. The etiology of CRC remains elusive and most likely combines environmental and genetic factors. The Kv2.1 potassium channel encoded by KC...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07605-7

    authors: Barbirou M,Woldu HG,Sghaier I,Bedoui SA,Mokrani A,Aami R,Mezlini A,Yacoubi-Loueslati B,Tonellato PJ,Bouhaouala-Zahar B

    更新日期:2020-11-10 00:00:00

  • SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer.

    abstract:BACKGROUND:Association between rectal or colon cancer risk and serine hydroxymethyltransferase 1 (SHMT1) C1420T or methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms was assessed. The serum total homocysteine (HCY), marker of folate metabolism was also investigated. METHODS:The SHMT1 and MTHFR genotypes w...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-525

    authors: Komlósi V,Hitre E,Pap E,Adleff V,Réti A,Székely E,Bíró A,Rudnai P,Schoket B,Müller J,Tóth B,Ottó S,Kásler M,Kralovánszky J,Budai B

    更新日期:2010-10-04 00:00:00

  • Alcohol-related breast cancer in postmenopausal women - effect of CYP19A1, PPARG and PPARGC1A polymorphisms on female sex-hormone levels and interaction with alcohol consumption and NSAID usage in a nested case-control study and a randomised controlled tr

    abstract:BACKGROUND:Alcohol consumption is associated with increased risk of breast cancer (BC), and the underlying mechanism is thought to be sex-hormone driven. In vitro and observational studies suggest a mechanism involving peroxisome proliferator-activated receptor gamma (PPARγ) in a complex with peroxisome proliferator-ac...

    journal_title:BMC cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s12885-016-2317-y

    authors: Kopp TI,Jensen DM,Ravn-Haren G,Cohen A,Sommer HM,Dragsted LO,Tjonneland A,Hougaard DM,Vogel U

    更新日期:2016-04-21 00:00:00

  • Small cell and non small cell lung cancer form metastasis on cellular 4D lung model.

    abstract:BACKGROUND:Metastasis is the main cause of death for lung cancer patients. The ex vivo 4D acellular lung model has been shown to mimic this metastatic process. However, the main concern is the model's lack of cellular components of the tumor's microenvironment. In this study, we aim to determine if the intact lung micr...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4358-x

    authors: Mishra DK,Miller RA,Pence KA,Kim MP

    更新日期:2018-04-18 00:00:00

  • Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma.

    abstract:BACKGROUND:Glioblastoma (GBM) tumors exhibit strong phenotypic differences that can be quantified using magnetic resonance imaging (MRI), but the underlying biological drivers of these imaging phenotypes remain largely unknown. An Imaging-Genomics analysis was performed to reveal the mechanistic associations between MR...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2659-5

    authors: Grossmann P,Gutman DA,Dunn WD Jr,Holder CA,Aerts HJ

    更新日期:2016-08-08 00:00:00

  • Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis.

    abstract:BACKGROUND:The objective of this systematic review and meta-analysis was to determine the prognostic value of total tumor-infiltrating lymphocytes (TILs) and subtypes of TILs (CD4+, CD8+, and FOXP3+) in triple-negative breast cancer (TNBC). METHODS:A systematic search of the MEDLINE, EMBASE, and Web of Science databas...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-020-6668-z

    authors: Gao G,Wang Z,Qu X,Zhang Z

    更新日期:2020-03-04 00:00:00

  • Granulomatosis with polyangiitis in a patient treated with dabrafenib and trametinib for BRAF V600E positive lung adenocarcinoma.

    abstract:BACKGROUND:Dabrafenib and trametinib combination therapy is approved for the treatment of patients with BRAF V600E positive tumors including melanoma and lung cancer. The effect of BRAF and MEK inhibitors on the immune system is not fully understood although a number of case reports indicate autoimmune side effects rel...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-6661-6

    authors: Dimou A,Barron G,Merrick DT,Kolfenbach J,Doebele RC

    更新日期:2020-03-04 00:00:00

  • Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates.

    abstract:BACKGROUND:The immune system plays an important role in the multifactorial biologic system during the development of neoplasias. However, the involvement of the inflammatory response in the promotion/control of malignant cells is still controversial, and the cell subsets and the mechanisms involved are poorly investiga...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-256

    authors: Estrela-Lima A,Araújo MS,Costa-Neto JM,Teixeira-Carvalho A,Barrouin-Melo SM,Cardoso SV,Martins-Filho OA,Serakides R,Cassali GD

    更新日期:2010-06-04 00:00:00

  • Improved nutrition in adolescents and young adults after childhood cancer - INAYA study.

    abstract:BACKGROUND:Multimodality treatment improves the chance of survival but increases the risk for long-term side effects in young cancer survivors, so-called" Adolescents and Young Adults"(AYAs). Compared to the general population AYAs have a 5 to 15-fold increased risk of cardiovascular morbidity. Thus, improving modifiab...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2896-7

    authors: Quidde J,von Grundherr J,Koch B,Bokemeyer C,Escherich G,Valentini L,Buchholz D,Schilling G,Stein A

    更新日期:2016-11-08 00:00:00

  • Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesion.

    abstract:BACKGROUND:Focal adhesion kinase (FAK) and Src are protein tyrosine kinases that physically and functionally interact to facilitate cancer progression by regulating oncogenic processes such as cell motility, survival, proliferation, invasiveness, and angiogenesis. METHOD:To understand how FAK affects oncogenesis throu...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-12

    authors: Sachdev S,Bu Y,Gelman IH

    更新日期:2009-01-12 00:00:00

  • HtrA1 as a promising tissue marker in cancer: a meta-analysis.

    abstract:BACKGROUND:HtrA1 is expressed in a variety of normal human tissues and seems to be involved in numerous physiological processes as well as tumorigenesis. This study reports the results of a meta-analysis that was performed: to compare HtrA1 expression as mRNA and protein, in cancer tissue versus non-cancer tissue and t...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-018-4041-2

    authors: Altobelli E,Angeletti PM,Morroni M,Profeta VF

    更新日期:2018-02-06 00:00:00

  • Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.

    abstract:BACKGROUND:Oncogene amplification and overexpression occur in tumor cells. Amplification status may provide diagnostic and prognostic information and may lead to new treatment strategies. Chromosomal regions 8p12, 8q24, 11q13, 17q12 and 20q13 are recurrently amplified in breast cancers. METHODS:To assess the frequenci...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-6-245

    authors: Letessier A,Sircoulomb F,Ginestier C,Cervera N,Monville F,Gelsi-Boyer V,Esterni B,Geneix J,Finetti P,Zemmour C,Viens P,Charafe-Jauffret E,Jacquemier J,Birnbaum D,Chaffanet M

    更新日期:2006-10-13 00:00:00

  • Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.

    abstract:BACKGROUND:Colorectal cancer (CRC) patients with metastatic disease can become cured if neoadjuvant treatment can enable a resection. The search for predictive biomarkers is often performed on primary tumours tissue. In order to assess the effectiveness of tailored treatment in regard to the primary tumour the differen...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4639-4

    authors: Mogensen MB,Rossing M,Østrup O,Larsen PN,Heiberg Engel PJ,Jørgensen LN,Hogdall EV,Eriksen J,Ibsen P,Jess P,Grauslund M,Nielsen HJ,Nielsen FC,Vainer B,Osterlind K

    更新日期:2018-07-20 00:00:00

  • Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapy.

    abstract:BACKGROUND:Budding is a complementary prognostic factor for colorectal cancer. In this study, we aimed to clarify the role of tumor budding in rectal cancer patients after preoperative chemoradiotherapy. METHODS:A total of 124 patients with rectal cancer treated with neoadjuvant chemoradiotherapy and consecutive surge...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6261-5

    authors: Trotsyuk I,Sparschuh H,Müller AJ,Neumann K,Kruschewski M,Horst D,Elezkurtaj S

    更新日期:2019-11-01 00:00:00

  • Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses.

    abstract:BACKGROUND:Neoadjuvant chemotherapy (NAC) is a standard treatment for stage II/III breast cancer patients, and response to NAC is a useful prognostic marker. Since its introduction, 6-8 cycles of NAC has become the standard regimen to improve the outcome of these patients. The purpose of this study is to evaluate the p...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2500-1

    authors: Yang Y,Im SA,Keam B,Lee KH,Kim TY,Suh KJ,Ryu HS,Moon HG,Han SW,Oh DY,Han W,Kim TY,Park IA,Noh DY

    更新日期:2016-07-21 00:00:00

  • Correction to: A novel coordination complex of platinum (PT) induces cell death in colorectal cancer by altering redox balance and modulating MAPK pathway.

    abstract::An amendment to this paper has been published and can be accessed via the original article. ...

    journal_title:BMC cancer

    pub_type: 已发布勘误

    doi:10.1186/s12885-020-07245-x

    authors: Al-Khayal K,Vaali-Mohammed MA,Elwatidy M,Traiki TB,Al-Obeed O,Azam M,Khan Z,Abdulla M,Ahmad R

    更新日期:2020-09-01 00:00:00

  • A multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL): rationale and design.

    abstract:BACKGROUND:Total mesorectal excision is the standard surgical treatment for mid- and low-rectal cancer. Laparoscopy represents a clear leap forward in the management of rectal cancer patients, offering significant improvements in post-operative measures such as pain, first bowel movement, and hospital length of stay. H...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/s12885-017-3200-1

    authors: Lelong B,de Chaisemartin C,Meillat H,Cournier S,Boher JM,Genre D,Karoui M,Tuech JJ,Delpero JR,French Research Group of Rectal Cancer Surgery (GRECCAR).

    更新日期:2017-04-11 00:00:00

  • A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America.

    abstract:BACKGROUND:Genetic counselling and testing for Lynch syndrome (LS) have recently been introduced in several Latin America countries. We aimed to characterize the clinical, molecular and mismatch repair (MMR) variants spectrum of patients with suspected LS in Latin America. METHODS:Eleven LS hereditary cancer registrie...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3599-4

    authors: Rossi BM,Palmero EI,López-Kostner F,Sarroca C,Vaccaro CA,Spirandelli F,Ashton-Prolla P,Rodriguez Y,de Campos Reis Galvão H,Reis RM,Escremim de Paula A,Capochin Romagnolo LG,Alvarez K,Della Valle A,Neffa F,Kalfayan PG,Spir

    更新日期:2017-09-05 00:00:00